| Targeting alpha-fetoprotein (AFP)–MHC complex with CAR T-cell therapy for liver cancer H Liu, Y Xu, J Xiang, L Long, S Green, Z Yang, B Zimdahl, J Lu, N Cheng, ... Clinical cancer research 23 (2), 478-488, 2017 | 212 | 2017 |
| A discontinuous hammerhead ribozyme embedded in a mammalian messenger RNA M Martick, LH Horan, HF Noller, WG Scott Nature 454 (7206), 899-902, 2008 | 208 | 2008 |
| Cytokine therapy reverses NK cell anergy in MHC-deficient tumors M Ardolino, CS Azimi, A Iannello, TN Trevino, L Horan, L Zhang, W Deng, ... The Journal of clinical investigation 124 (11), 4781-4794, 2014 | 197 | 2014 |
| Intersubunit movement is required for ribosomal translocation LH Horan, HF Noller Proceedings of the National Academy of Sciences 104 (12), 4881-4885, 2007 | 165 | 2007 |
| A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release Y Xu, Z Yang, LH Horan, P Zhang, L Liu, B Zimdahl, S Green, J Lu, ... Cell discovery 4 (1), 62, 2018 | 101 | 2018 |
| The hammerhead ribozyme: structure, catalysis, and gene regulation WG Scott, LH Horan, M Martick Progress in molecular biology and translational science 120, 1-23, 2013 | 93 | 2013 |
| The sarcin–ricin loop of 23S rRNA is essential for assembly of the functional core of the 50S ribosomal subunit L Lancaster, NJ Lambert, EJ Maklan, LH Horan, HF Noller Rna 14 (10), 1999-2012, 2008 | 60 | 2008 |
| Antibody/T-cell receptor chimeric constructs and uses thereof J Lu, Z Yang, C Liu, H Liu, Y Xu, S Yan, VW Chan, L Horan US Patent 10,098,951, 2018 | 14 | 2018 |
| Antibody/T-cell receptor chimeric constructs and uses thereof J Lu, Z Yang, C Liu, H Liu, Y Xu, S Yan, VW Chan, L Horan US Patent 11,421,013, 2022 | 12 | 2022 |
| Antibody/T-cell receptor chimeric constructs and uses thereof J Lu, Z Yang, C Liu, H Liu, Y Xu, S Yan, VW Chan, L Horan US Patent 10,464,988, 2019 | 12 | 2019 |
| Biochemical identification of new proteins involved in splicing repression at the Drosophila P-element exonic splicing silencer L Horan, JC Yasuhara, LA Kohlstaedt, DC Rio Genes & development 29 (21), 2298-2311, 2015 | 9 | 2015 |
| Antibody/T-cell receptor chimeric constructs and uses thereof J Lu, Z Yang, C Liu, H Liu, Y Xu, S Yan, VW Chan, L Horan US Patent 10,822,389, 2020 | 5 | 2020 |
| Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof H Liu, P Zhang, L Horan, Y Xu, BK Staley, L Liu, YUN Hongruo US Patent 10,822,413, 2020 | 3 | 2020 |
| Antibody/t-cell receptor chimeric constructs and uses thereof J Lu, Z Yang, C Liu, H Liu, Y Xu, S Yan, VW Chan, L Horan US Patent App. 17/181,913, 2021 | 2 | 2021 |
| Anti-CD19 ARTEMIS™ T cells prevent excessive inflammatory cytokine release, including IL-6, in a co-culture model of CRS H Liu, LH Horan, SA Grupp, DM Barrett, C Liu Cancer Research 78 (13_Supplement), 1537-1537, 2018 | 2 | 2018 |
| Studies on the mechanisms of translocation and termination HF Noller, DN Ermolenko, A Korostelev, M Laurberg, J Zhu, H Asahara, ... Ribosomes: Structure, Function, and Dynamics, 349-360, 2011 | 2 | 2011 |
| Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof H Liu, P Zhang, L Horan, Y Xu, BK Staley, L Liu, YUN Hongruo US Patent App. 16/608,366, 2021 | 1 | 2021 |
| Antibody/t-cell receptor chimeric constructs and uses thereof J Lu, Z Yang, C Liu, H Liu, Y Xu, S Yan, VWF Chan, L Horan PH Patent App. 12,018,500,861 A, 2018 | 1 | 2018 |
| Antibody/t-cell receptor chimeric constructs and uses thereof J Lu, Z Yang, C Liu, H Liu, Y Xu, S Yan, VW Chan, L Horan US Patent App. 17/716,667, 2022 | | 2022 |
| Cells expressing chimeric antigen receptors and chimeric stimulating receptors and uses thereof YUN Hongruo, J Cui, P Zhang, Y Xu, L Horan, S Xu, G Xiong, S Li, Y Xu, ... US Patent App. 17/628,120, 2022 | | 2022 |
